GENE ONLINE|News &
FDA Approves Merilog: What It Means for the Diabetes Biosimilar Market
Merilog is the FDA's first approved rapid-acting insulin biosimilar and the third biosimilar insulin overall. Image: Shutterstock
The U.S. Food and Drug Administration (FDA) has approved Merilog (insulin aspart-szjj), a biosimilar to NovoLog (insulin aspart), marking a significant expansion in diabetes treatment …
FDA Approves Merilog: What It Means for the Diabetes Biosimilar Market Read More »
GO Prime with only $1.49 now
LATEST
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
PYGO2 Overexpression Linked to Increased Plasma Cell Proliferation in Multiple Myeloma Patients with 1q21 Amplification
2026-07-10
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
